U.S. Renewable Energy Stock News

This article explores whether Grab Holdings at around US$3.77 may represent a bargain or a value trap, and walks through key signals that can help you judge the stock for yourself. The share price performance has been mixed: a 1.3% decline over the last week, a 6.5% gain over the last month, returns of 25.8% decline year to date and 23.5% decline over the past year, set against a 17.4% gain over three years and a 65.9% decline over five years. Recent news around Grab Holdings has focused on...

Textron Aviation, a unit of Textron (NYSE:TXT), has opened a significantly expanded service facility at Essendon Fields Airport in Melbourne to support customers across Asia-Pacific. The company has also begun initial deliveries of its new Cessna Citation Ascend business jets to NetJets, marking the first handovers of the model. For Textron, aviation services and business jets sit at the core of its aerospace focus, and the Asia-Pacific region is an important area for corporate and charter...

Eastman Chemical Company's ( NYSE:EMN ) stock was strong despite it releasing a soft earnings report last week. We...

Cognex Corporation ( NASDAQ:CGNX ) just released its quarterly report and things are looking bullish. The company beat...

Otis Worldwide (NYSE:OTIS) has named co-champions in its latest "Made to Move Communities" student challenge. The winning teams focused on STEM and AI concepts designed to support vulnerable communities during natural disasters. The program highlights student projects that address real-world mobility and access issues in crisis situations. Otis Worldwide, best known for elevators, escalators and related services, is using this global challenge to connect its core focus on mobility with...

As you might know, Vericel Corporation ( NASDAQ:VCEL ) just kicked off its latest quarterly results with some very...

As you might know, Duke Energy Corporation ( NYSE:DUK ) just kicked off its latest first-quarter results with some very...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Arrow...

Investors were disappointed with The Marcus Corporation's ( NYSE:MCS ) earnings, despite the strong profit numbers. We...

Roper Technologies, Inc.'s ( NASDAQ:ROP ) robust recent earnings didn't do much to move the stock. We believe that...

Clearwater Analytics Holdings (CWAN) closed out FY 2025 with Q4 revenue of US$217.5 million and a basic EPS loss of US$0.04, as net income excluding extra items came in at a loss of US$12.1 million. Over recent periods the company has seen quarterly revenue move from US$126.5 million in Q4 FY 2024 to US$217.5 million in Q4 FY 2025, while basic EPS shifted from US$1.85 a share in Q4 FY 2024 to a loss of US$0.04 a share in the latest quarter. This sets up a results season in which investors are...

If you are wondering whether Ferguson Enterprises at around US$246.53 is still worth your attention, it helps to start by separating price moves from underlying value. The stock has seen a 7.9% decline over the last 7 days, set against returns of 4.5% over 30 days, 9.6% year to date, 46.3% over 1 year, 78.6% over 3 years and 109.5% over 5 years. This naturally raises questions about how much future strength or risk is already reflected in the price. Recent coverage of Ferguson Enterprises...

MNTN, Inc. recently reported first-quarter 2026 results, with sales rising to US$73.67 million and net income improving to US$8.76 million, reversing a net loss a year earlier and lifting basic earnings per share from continuing operations to US$0.12. On the same day, the company launched QuickFrame AI 3.0, expanding its AI-powered creative platform into a full production workflow that lets brands rapidly generate, edit, and publish multi-format video ads across major digital and TV...

Affirm Holdings (AFRM) opened its Q2 2026 update with total revenue of US$1.1b and basic EPS of US$0.39, alongside trailing twelve month revenue of US$3.7b and EPS of US$0.86 that put profitability firmly in focus. The company has seen quarterly revenue move from US$866.4m in Q2 2025 to US$1.1b in Q2 2026, while basic EPS shifted from US$0.25 to US$0.39 over the same period. This sets up this print as a key checkpoint on whether margins are starting to scale more consistently. See our full...

Wondering whether Intuitive Machines stock still offers value after its recent volatility, or if you might be turning up late to the story? The stock closed at US$24.11, with a 4.9% decline over the last 7 days, a 6.1% gain over 30 days, a 34.8% return year to date, and a 157.9% return over the past year. Recent headlines around Intuitive Machines have kept the stock in focus, with investors paying closer attention to how its projects translate into long term potential. This context helps...

eXp World Holdings (AGNT) recently drew attention after eXp Commercial added veteran broker Mario J Alvarez Jr, whose two decades in commercial real estate align with the company’s effort to grow its investment sales presence. See our latest analysis for eXp World Holdings. At a share price of $6.60, eXp World Holdings has a 30 day share price return of 10.18% and a 7 day gain of 2.48%. However, the year to date share price return of 27.47% and 90 day share price return of 23.79% point to...

If you are wondering whether Grindr stock is priced fairly or if the current level still leaves room for value, you need to look past headlines and into the numbers that shape valuation. Over the last month the share price has moved to US$13.81, with returns of 3.3% over 7 days, 12.4% over 30 days and 3.8% year to date, set against a 43.5% loss over the past year and a 124.2% gain over three years. Recent coverage has focused on Grindr as a listed platform business and how investors are...

If you are trying to figure out whether Apellis Pharmaceuticals is attractively priced today, it helps to start with how the current market value lines up against different ways of estimating fair value. The stock last closed at US$41.01, with returns of 0.1% over 7 days, 0.8% over 30 days, 58.6% year to date and 130.3% over the past year, alongside 3 year and 5 year returns of 53.7% decline and 10.1% decline respectively. This gives a mixed picture for anyone thinking about entry or exit...

Earlier this week, enGene Therapeutics reported interim Phase 2 LEGEND trial results for its bladder cancer gene therapy detalimogene voraplasmid, revealing a 54% complete response rate but weaker 12‑month durability than previously expected, alongside generally manageable side effects and low disease progression. The mixed efficacy profile has triggered analyst downgrades and shareholder-rights investigations, highlighting how a single data update can rapidly reshape perceptions of a...

NiSource (NYSE:NI) announced new and expanded partnerships with Amazon and Alphabet that are expected to support $1.4 billion in customer savings over 15 years. Alongside these partnerships, the company updated its long term adjusted EPS growth outlook to a range of 9% to 10% through 2033. For investors watching utilities, NiSource stands out with a current share price of $47.02 and a 5 year return of 115.2%. The stock has also returned 21.9% over the past year and 83.7% over 3 years,...

This article examines whether Primo Brands, trading at around US$22.24, currently represents value or risk by exploring what the share price might be implying. The stock has returned 9.1% over the last 7 days, 21.3% over the last 30 days and 37.4% year to date, while the 1 year return reflects a 29.8% decline and the 3 and 5 year returns are 69.8% and 48.4% respectively. Recent market interest in Primo Brands appears tied to broader investor attention on beverage companies listed in the US...

Encore Capital Group (NasdaqGS:ECPG) is asking shareholders to approve an amendment to its corporate charter. The change would exculpate company officers from personal liability for monetary damages tied to breaches of the duty of care. The proposal is scheduled for a vote at the upcoming annual shareholder meeting. Encore Capital Group operates in the consumer debt buying and collections space, where regulatory scrutiny, legal risk and reputational considerations tend to be front and...

If you are wondering whether Alkermes at around US$35.40 still offers value, it helps to step back and look at what the recent share performance might be implying about expectations. The stock has returned 5.0% over the last 7 days, 7.2% over 30 days, 25.3% year to date and 16.5% over the past year. This puts recent pricing in clear focus for anyone weighing upside against risk. Recent coverage has centered on Alkermes’ position in the pharmaceuticals and biotech space and how its pipeline...

Wondering whether Privia Health Group at around US$23.99 is offering fair value or a potential opportunity? This article breaks down what the current price may be telling you. The stock has been volatile recently, with a 3.5% decline over the last 7 days, a 7.2% gain over the last 30 days, and year to date returns of 2.3% after a 4.3% loss over the past year. Those mixed returns come against a backdrop of ongoing interest in healthcare services companies focused on physician enablement and...